Tocagen's Series C Round

Tocagen raised a round of funding on November 23, 2009.

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments fo…

Articles about Tocagen's Series C Round: